Robert Ianonne

2020

In 2020, Robert Ianonne earned a total compensation of $3.1M as Executive Vice President, Research and Development and Chief Medical Officer at Jazz Pharmaceuticals, a 15% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$450,000
Option Awards$874,522
Salary$592,308
Stock Awards$1,221,479
Other$11,172
Total$3,149,481

Ianonne received $1.2M in stock awards, accounting for 39% of the total pay in 2020.

Ianonne also received $450K in non-equity incentive plan, $874.5K in option awards, $592.3K in salary and $11.2K in other compensation.

Rankings

In 2020, Robert Ianonne's compensation ranked 3,690th out of 13,090 executives tracked by ExecPay. In other words, Ianonne earned more than 71.8% of executives.

ClassificationRankingPercentile
All
3,690
out of 13,090
72nd
Division
Manufacturing
1,453
out of 5,621
74th
Major group
Chemicals And Allied Products
547
out of 2,254
76th
Industry group
Drugs
474
out of 1,954
76th
Industry
Pharmaceutical Preparations
357
out of 1,459
76th

Pay ratio

Robert Ianonne's Pay$3,149,481
Median Employee's Pay$234,935
Pay Ratio

13

to 1

In 2020, the annual total compensation of Robert Ianonne was $3,149,481.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.

The ratio of Robert Ianonne's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on June 11, 2021.

Ianonne's colleagues

We found five more compensation records of executives who worked with Robert Ianonne at Jazz Pharmaceuticals in 2020.

2020

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2020

Kim Sablich

Jazz Pharmaceuticals

Executive Vice President and General Manager, North America

2020

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2020

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2020

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like